Steris Plc (STE) has recently been a focal point for various asset management firms, with companies like
Fulton Bank N.A., Congress Asset Management Co. MA, Mather Group LLC and others making significant adjustments to their stock holdings. Meanwhile, certain insiders have sold off shares, including the company's SVP and president of healthcare, Cary Majors. Despite mixed market sentiment due to fluctuating fundamentals, STE stock hit a new 52-week high due to strong Q4 2024 earnings which matched estimates, showing
revenue and earnings growth, and leading to positive ratings from firms such as StockNews.com. The company has also seen recent strategic actions, such as selling its dental segment to
HuFriedy Group and Peak Rock Capital for a sizeable sum, aiming to focus on debt reduction. Nonetheless, there are some concerns over the company's dental sales and
margin woes, as well as the planned closure of plants in Brazil and England, with the possible loss of fewer than 200 jobs.
Steris Plc STE News Analytics from Wed, 05 Dec 2018 08:00:00 GMT to Sun, 23 Jun 2024 01:01:46 GMT -
Rating 7
- Innovation 2
- Information 8
- Rumor -6
